PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Regeneron Pharmaceuticals, Inc. (REGN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS75886F1075
CUSIP75886F107
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$106.17B
EPS$34.73
PE Ratio27.85
PEG Ratio1.56
Revenue (TTM)$13.12B
Gross Profit (TTM)$7.02B
EBITDA (TTM)$4.65B
Year Range$684.80 - $998.33
Target Price$1,041.59
Short %1.47%
Short Ratio2.65

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with REGN

Regeneron Pharmaceuticals, Inc.

Popular comparisons: REGN vs. VRTX, REGN vs. SNY, REGN vs. QQQ, REGN vs. VTI, REGN vs. SPY, REGN vs. V, REGN vs. NVO, REGN vs. MRK, REGN vs. VOO, REGN vs. VHT

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Regeneron Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


1,000.00%2,000.00%3,000.00%4,000.00%5,000.00%OctoberNovemberDecember2024FebruaryMarch
4,474.20%
1,283.00%
REGN (Regeneron Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Regeneron Pharmaceuticals, Inc. had a return of 10.02% year-to-date (YTD) and 16.85% in the last 12 months. Over the past 10 years, Regeneron Pharmaceuticals, Inc. had an annualized return of 12.43%, outperforming the S&P 500 benchmark which had an annualized return of 10.96%.


PeriodReturnBenchmark
Year-To-Date10.02%10.04%
1 month-2.32%3.53%
6 months16.06%22.79%
1 year16.85%32.16%
5 years (annualized)18.72%13.15%
10 years (annualized)12.43%10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20247.34%2.47%
202311.40%-0.43%-5.23%5.63%6.61%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
REGN
Regeneron Pharmaceuticals, Inc.
0.87
^GSPC
S&P 500
2.76

Sharpe Ratio

The current Regeneron Pharmaceuticals, Inc. Sharpe ratio is 0.87. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.00OctoberNovemberDecember2024FebruaryMarch
0.87
2.76
REGN (Regeneron Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Regeneron Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-15.00%-10.00%-5.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-2.72%
0
REGN (Regeneron Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Regeneron Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Regeneron Pharmaceuticals, Inc. was 91.81%, occurring on Apr 14, 2005. Recovery took 1520 trading sessions.

The current Regeneron Pharmaceuticals, Inc. drawdown is 2.72%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.81%Mar 1, 20001287Apr 14, 20051520Apr 27, 20112807
-86.67%Feb 7, 1992733Dec 30, 1994446Oct 4, 19961179
-77.42%Oct 9, 1996628Apr 7, 1999223Feb 23, 2000851
-53.84%Aug 6, 20151044Sep 27, 2019168May 29, 20201212
-53.23%Apr 3, 199180Jul 25, 1991133Feb 3, 1992213

Volatility

Volatility Chart

The current Regeneron Pharmaceuticals, Inc. volatility is 3.70%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%OctoberNovemberDecember2024FebruaryMarch
3.70%
2.82%
REGN (Regeneron Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Regeneron Pharmaceuticals, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items